Your browser doesn't support javascript.
loading
Mir-98 reduces the expression of HMGA2 and promotes osteogenic differentiation of mesenchymal stem cells.
Gao, X-L; Cao, M-G; Ai, G-G; Hu, Y-B.
Afiliación
  • Gao XL; Department of Spine Surgery, Sixth Affiliated Hospital of Xinjiang Medical University, Ürümqi, China. hyb4499@126.com.
Eur Rev Med Pharmacol Sci ; 22(11): 3311-3317, 2018 06.
Article en En | MEDLINE | ID: mdl-29917180
OBJECTIVE: To study effects of microRNA-98 (miR-98) on osteogenic differentiation of mesenchymal stem cells (MSCs). PATIENTS AND METHODS: We predicted target gene of miR-98 with software test, and detected expression changes of miR-98, as well as its target gene HMGA2, in the process of osteogenic differentiation of mesenchymal stem cells. After transfection of miR-98 mimic and HMGA2 siRNA, we induced osteogenic differentiation and detected expression changes of osteogenic differentiation markers (RUNX2, ALP, OCN, and BSP). RESULTS: MiR-98 combined directly with target gene HMGA2 and inhibited its expression. During the process of osteogenic differentiation, expression of miR-98 was up-regulated, while HMGA2 expression was down-regulated. In addition, the expression of osteogenesis maker genes increased in cells being transfected with miR-98 mimics and HMGA2 siRNA. CONCLUSIONS: MiR-98 can promote osteogenic differentiation of mesenchymal stem cells by targeting gene HMGA2.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteogénesis / Diferenciación Celular / Regulación de la Expresión Génica / Proteína HMGA2 / MicroARNs / Células Madre Mesenquimatosas Límite: Humans Idioma: En Revista: Eur Rev Med Pharmacol Sci Asunto de la revista: FARMACOLOGIA / TOXICOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteogénesis / Diferenciación Celular / Regulación de la Expresión Génica / Proteína HMGA2 / MicroARNs / Células Madre Mesenquimatosas Límite: Humans Idioma: En Revista: Eur Rev Med Pharmacol Sci Asunto de la revista: FARMACOLOGIA / TOXICOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Italia